Publications

My publications cover the range of areas I have worked in, including the health economics of cancer care, occupational therapy rehabilitation and breast cancer clinical practice guidelines.

  1. Pearce A, Mulhern B, Watson V, Viney R. (2019). How are debriefing questions used in health discrete choice experiments? An online survey. Value in Health: Early online
  2. Smith A, Bamgboje-Ayodele A, Butow P, Klein B, Turner J, Sharpe L, Fardell J, Beatty L, Pearce A, Thewes B, Beith J, Costa D, Community Advisory Group Members and Girgis A. (2019). Development and usability evaluation of an online self-management intervention for fear of cancer recurrence (iConquerFear). Psycho-Oncology: In press – pre-print. 
  3. Barchuk A, Bespalov A, Huhtala H, Chimed T, Belyaev A, Moore M, Anttila A, Auvinen A, Pearce A, Soerjomataram I. (2019). Productivity losses associated with premature mortality due to cancer in Russia: A population-wide study covering 2001-2030. Scandinavian Journal of Public Health: Early online. 
  4. Pearce A, Tomalin B, Kaambwa B, Horevoorts N, Duijts S, Mols F, van de Poll-Franse L, Koczwara B. (2018). Financial toxicity is more than costs of care: the relationship between employment and financial toxicity in long-term cancer survivors. Journal of Cancer Survivorship: Early online. 
  5. Pearce A, Sharp L, Hanly P, Barchuk A, Bray F, de Camargo Cancel M, Gupta P, Meheus F, Qiao YL, Sitas F, Wang SM, Soerjomataram I (2018). Productivity losses due to premature mortality from cancer in Brazil, Russia, India, China and South Africa (BRICS): A population-based comparison. Cancer Epidemiology: 53, 27-34.
  6. Shaw J, Pearce A, Lopez AL, Price M. (2018). Clinical anxiety disorders in the context of cancer: a scoping review of impact on resource use and health care costs. European Journal of Cancer Care, 27(5).
  7. Pearce A, Haas M, Viney R, Pearson SA, Haywood P, Brown C, Ward R (2017). Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study. PLOS One, 12(10): e0184360.
  8. Hanly P, Pearce A, Sharp L (2017). Cancer and productivity loss in the Irish economy: An employer’s perspective. Irish Journal of Management, 36(1): 5-20
  9. Thomas AA, Pearce A, O’Neill C, Molcho M, Sharp L. (2016). Urban-rural differences in cancer-directed surgery and survival of patients with non-small cell lung cancer. Journal Epidemiology and Community Health.
  10. Pearce A, Bradley C, Hanly P, O’Neill C, Thomas AA, Molcho M, Sharp L. (2016). Projecting productivity losses for cancer-related mortality 2011 – 2030. BMC Cancer. 16:804
  11. Thomas AA, Pearce A, Sharp L, Gardiner RA, Chambers S, Aitken JA, Molcho M, Baade P. (2016). Socioeconomic disadvantage but not remoteness affects short-term survival in prostate cancer: A population-based study using competing risks. Asia-Pacific Journal of Clinical Oncology.
  12. Pearce A, Ryan F (joint first author), Drummond F, Thomas AA, Timmons A, Sharp L (2015). Comparing the costs of three prostate cancer follow-up strategies: a cost minimisation analysis. Supportive Care in Cancer. Early online 06 August 2015.
  13. Pearce A, Hanly P, Timmons A, Walsh PM, O’Neill C, O’Sullivan E, Gooberman-Hill R, Thomas AA, Gallagher P, Sharp L (2015). Productivity losses associated with head and neck cancer using the Human Capital and Friction Cost approaches. App Health Economics and Health Policy. Early online 19 February 2015.
  14. Pearce AM, Timmons A, O’Sullivan E, Gallagher P, Gooberman-Hill R, Thomas AA, Molcho M, Butow P, Sharp L (2015). Long-term workforce participation patterns following head and neck cancer. Journal of Cancer Survivorship, 9(1):30-39.
  15. Pearce A, Haas M, Viney R, Haywood P, Pearson SA, van Gool K, Srasuebkul P, Ward R (2014). Can administrative data be used to measure chemotherapy side effects? Expert Rev Pharmacoecon Outcomes Res. Early online 1-8.
  16. Sharp L, Deady S, Gallagher P, Molcho M, Pearce A, Thomas AA, Timmons A, Comber H (2014). The magnitude and characteristics of the population of cancer survivors: using population-based estimates of cancer prevalence to inform service planning for survivorship care. BMC Cancer. 14:767
  17. Thomas AA, Gallagher P, O’Ceilleachair A, Pearce A, Sharp L, Molcho M (2014). Distance from treating hospital and colorectal cancer survivors’ quality of life: a gendered analysis. Supportive Care in Cancer. 23(3):741-751.
  18. Hanly P, Pearce AM, Sharp L (2014). The cost of premature cancer-related mortality: a review and assessment of the evidence. Expert Review of Pharmacoeconomics and Outcomes Research. 14(3), 355-377.
  19. Thomas AA, Timmons A, Molcho M, Pearce A, Gallagher P, Butow P, O’Sullivan E, Gooberman-Hill R, O’Neill C, Sharp L (2014). Quality of life in urban and rural settings: A study of head and neck cancer survivors. Oral Oncology. 50(7), 679-682.
  20. Pearce A, Haas M, Viney R (2013). Are the true impacts of adverse events considered in economic models of antineoplastic drugs? A systematic review. Journal of Applied Health Economics and Health Policy. 11(6), 619-637.
  21. Noushi F, Spillane AJ, Uren RF, Cooper R, Allwright S, Snook KL, Gillet D, Pearce A, Gebski V (2013). High discordance rates between sub-areolar and peri-tumoural breast lymphoscintigraphy. European Journal of Surgical Oncology. 39(10), 1053-1060
  22. Pearce A, Van Gool K, Haywood P, Haas M (2013).  Delays in access to affordable medicines – putting policy into perspective: Authors’ response. Australian Health Review. 38(1), 16-17.
  23. Pearce A, Van Gool K, Haywood P, Haas M (2012).  Delays in access to affordable medicines – putting policy into perspective. Australian Health Review, 36(4), 412-418
  24. Pearce A, Smead J, Cameron I (2012).  Retrospective cohort study of accident outcomes for individuals who have successfully undergone driver assessment following stroke.  Australian Occupational Therapy Journal. 59(1), 56-62